UBS Investment Bank, J.P. Morgan, Citigroup, Piper Jaffray
Morgan Joseph TriArtisan
For IPO Boutique's "scale of 1 to 5" BUY rating on Myriant Corporation, and our comprehensive analysis, click the "Buy Market Research" link.
About Myriant Corporation (adapted from Myriant Corporation prospectus): Myriant is an industrial biotechnology company focused on becoming a low-cost producer of biobased chemicals. They have designed a process that uses proprietary microorganisms to convert a variety of sugars into chemical precursors, called "intermediates." Myriant plans to sell those "biobased" intermediates into the large and growing petrochemicals industry.
This description is adapted from Myriant prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus..
Share this IPO Profile:
IPO Boutique aggregates information on public companies and private companies, such as Myriant "MYRT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.